Candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet — RxCUI 578325
RxNorm drug concept · Semantic clinical drug
RxCUI 578325
Semantic clinical drug · SCD
● Current RxNorm concept 17 FDA products
41 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI578325
Official nameCandesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascandesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet
FDA products mapped17
Package NDCs mapped41
Reported Medicaid activity (SDUD)2,037 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Candesartan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Candesartan is mainly used to treat high blood pressure — in adults and even in children as young as 1 year old. It's also used in adults with heart failure to reduce the risk of s...
- You can take candesartan with or without food — it doesn't affect how the drug works either way. As for timing, it's usually taken once a day, and the most important thing is to ta...
- Does it matter what time of day I take it, or if I take it with food?
- Most people tolerate candesartan well. You might notice some dizziness — especially when you first start or if your dose changes — along with occasional headache or a stuffy nose....
🕸️ Concept Web — How Candesartan cilexetil 16 MG / hydrochlorothiazid... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet
RxCUI 578325 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Candesartan
214354IN -
Hydrochlorothiazide
5487IN -
Candesartan / hydrochlorothiazide
284628MIN -
Candesartan cilexetil
135481PIN
-
Candesartan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Atacand HCT
284662BN
-
Atacand HCT
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Candesartan / hydrochlorothiazide Oral Tablet
374934SCDF -
Candesartan cilexetil / hydrochlorothiazide Oral Tablet
2645863SCDFP -
Candesartan / hydrochlorothiazide Oral Product
1156609SCDG -
Candesartan / hydrochlorothiazide Pill
1156610SCDG -
Candesartan cilexetil / hydrochlorothiazide Oral Product
2659327SCDGP -
Candesartan cilexetil / hydrochlorothiazide Pill
2663669SCDGP -
Candesartan / hydrochlorothiazide Oral Tablet [Atacand HCT]
805854SBDF -
Candesartan cilexetil / hydrochlorothiazide Oral Tablet [Atacand HCT]
2658646SBDFP - +5 more in this family
-
Candesartan / hydrochlorothiazide Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Candesartan cilexetil 16 MG
577775SCDC -
Hydrochlorothiazide 12.5 MG
316047SCDC -
Candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]
805863SBD -
Candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG [Atacand HCT]
805861SBDC
-
Candesartan cilexetil 16 MG
Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Candesartan cilexetil 16 MG
SCDC · 577775 -
Hydrochlorothiazide 12.5 MG
SCDC · 316047 -
Candesartan / hydrochlorothiazide Oral Tablet
SCDF · 374934 -
Candesartan cilexetil / hydrochlorothiazide Oral Tablet
SCDFP · 2645863 -
Candesartan / hydrochlorothiazide Oral Product
SCDG · 1156609 -
Candesartan / hydrochlorothiazide Pill
SCDG · 1156610 -
Candesartan cilexetil / hydrochlorothiazide Oral Product
SCDGP · 2659327 -
Candesartan cilexetil / hydrochlorothiazide Pill
SCDGP · 2663669
Brand-Name Concepts
-
Candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]
SBD · 805863 -
Candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG [Atacand HCT]
SBDC · 805861 -
Candesartan / hydrochlorothiazide Oral Tablet [Atacand HCT]
SBDF · 805854 -
Candesartan cilexetil / hydrochlorothiazide Oral Tablet [Atacand HCT]
SBDFP · 2658646 -
Atacand HCT Oral Product
SBDG · 1172183 -
Atacand HCT Pill
SBDG · 1172182 -
Atacand HCT
BN · 284662
📦 FDA Products & Package NDCs
17 products · 41 package NDCs
41 package NDCs map to RxCUI 578325 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-3001-77 | 90 TABLET in 1 BOTTLE, PLASTIC (0378-3001-77) | Candesartan Cilexetil and Hydrochlorothiazide | Mylan Pharmaceuticals Inc. | 2012-12-04 |
| 00378-3003-77 | 90 TABLET in 1 BOTTLE, PLASTIC (0378-3003-77) | Candesartan Cilexetil and Hydrochlorothiazide | Mylan Pharmaceuticals Inc. | 2012-12-04 |
| 33342-0131-10 | 90 TABLET in 1 BOTTLE (33342-131-10) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0131-12 | 10 BLISTER PACK in 1 CARTON (33342-131-12) / 10 TABLET in 1... | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0131-15 | 500 TABLET in 1 BOTTLE (33342-131-15) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0131-51 | 300 TABLET in 1 BOTTLE (33342-131-51) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0132-10 | 90 TABLET in 1 BOTTLE (33342-132-10) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0132-12 | 10 BLISTER PACK in 1 CARTON (33342-132-12) / 10 TABLET in 1... | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0132-15 | 500 TABLET in 1 BOTTLE (33342-132-15) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0132-51 | 300 TABLET in 1 BOTTLE (33342-132-51) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0133-10 | 90 TABLET in 1 BOTTLE (33342-133-10) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0133-12 | 10 BLISTER PACK in 1 CARTON (33342-133-12) / 10 TABLET in 1... | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0133-15 | 500 TABLET in 1 BOTTLE (33342-133-15) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 33342-0133-51 | 300 TABLET in 1 BOTTLE (33342-133-51) | Candesartan Cilexetil and Hydrochlorothiazide | Macleods Pharmaceuticals Limited | 2015-03-07 |
| 43547-0459-09 | 90 TABLET in 1 BOTTLE (43547-459-09) | candesartan cilexetil and hydrochlorothiazide | Solco Healthcare LLC | 2017-11-20 |
| 43547-0459-50 | 500 TABLET in 1 BOTTLE (43547-459-50) | candesartan cilexetil and hydrochlorothiazide | Solco Healthcare LLC | 2017-11-20 |
| 43547-0460-09 | 90 TABLET in 1 BOTTLE (43547-460-09) | candesartan cilexetil and hydrochlorothiazide | Solco Healthcare LLC | 2017-11-20 |
| 43547-0460-50 | 500 TABLET in 1 BOTTLE (43547-460-50) | candesartan cilexetil and hydrochlorothiazide | Solco Healthcare LLC | 2017-11-20 |
| 43547-0461-09 | 90 TABLET in 1 BOTTLE (43547-461-09) | candesartan cilexetil and hydrochlorothiazide | Solco Healthcare LLC | 2017-11-20 |
| 43547-0461-50 | 500 TABLET in 1 BOTTLE (43547-461-50) | candesartan cilexetil and hydrochlorothiazide | Solco Healthcare LLC | 2017-11-20 |
| 62559-0650-90 | 90 TABLET in 1 BOTTLE (62559-650-90) | ATACAND HCT | ANI Pharmaceuticals, Inc. | 2018-10-01 |
| 62559-0651-90 | 90 TABLET in 1 BOTTLE (62559-651-90) | ATACAND HCT | ANI Pharmaceuticals, Inc. | 2018-10-01 |
| 62559-0652-90 | 90 TABLET in 1 BOTTLE (62559-652-90) | ATACAND HCT | ANI Pharmaceuticals, Inc. | 2018-10-01 |
| 62559-0660-90 | 90 TABLET in 1 BOTTLE (62559-660-90) | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | 2018-09-26 |
| 62559-0661-90 | 90 TABLET in 1 BOTTLE (62559-661-90) | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | 2018-09-26 |
| 62559-0662-90 | 90 TABLET in 1 BOTTLE (62559-662-90) | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | 2018-09-26 |
| 70771-1325-00 | 1000 TABLET in 1 BOTTLE (70771-1325-0) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1325-01 | 100 TABLET in 1 BOTTLE (70771-1325-1) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1325-03 | 30 TABLET in 1 BOTTLE (70771-1325-3) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1325-04 | 10 BLISTER PACK in 1 CARTON (70771-1325-4) / 10 TABLET in 1... | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1325-09 | 90 TABLET in 1 BOTTLE (70771-1325-9) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1326-00 | 1000 TABLET in 1 BOTTLE (70771-1326-0) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1326-01 | 100 TABLET in 1 BOTTLE (70771-1326-1) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1326-03 | 30 TABLET in 1 BOTTLE (70771-1326-3) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1326-04 | 10 BLISTER PACK in 1 CARTON (70771-1326-4) / 10 TABLET in 1... | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1326-09 | 90 TABLET in 1 BOTTLE (70771-1326-9) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1327-00 | 1000 TABLET in 1 BOTTLE (70771-1327-0) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1327-01 | 100 TABLET in 1 BOTTLE (70771-1327-1) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1327-03 | 30 TABLET in 1 BOTTLE (70771-1327-3) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1327-04 | 10 BLISTER PACK in 1 CARTON (70771-1327-4) / 10 TABLET in 1... | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
| 70771-1327-09 | 90 TABLET in 1 BOTTLE (70771-1327-9) | candesartan cilexetil and hydrochlorothiazide | Zydus Lifesciences Limited | 2018-04-14 |
Observed labelers:
Zydus Lifesciences Limited (15) ·
Macleods Pharmaceuticals Limited (12) ·
ANI Pharmaceuticals, Inc. (6) ·
Solco Healthcare LLC (6) ·
Mylan Pharmaceuticals Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.